Skip to main content
Erschienen in: Journal of Neurology 11/2014

01.11.2014 | Original Communication

Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration

verfasst von: Satoshi Yamashita, Naomi Sakashita, Taro Yamashita, Nozomu Tawara, Masayoshi Tasaki, Kensuke Kawakami, Yoshihiro Komohara, Yukio Fujiwara, Masashi Kamikawa, Takenobu Nakagawa, Teruyuki Hirano, Yasushi Maeda, Masato Hasegawa, Motohiro Takeya, Yukio Ando

Erschienen in: Journal of Neurology | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Pathological changes in corticobasal degeneration (CBD) consist of abnormal deposition of the microtubule-associated protein tau. However, the simultaneous accumulation of different misfolded proteins in the brain can be observed in many neurodegenerative diseases with significantly longer disease durations. We encountered a patient with CBD who survived for an extremely long period (18 years) after the diagnosis. We performed an autopsy to elucidate the effect of the longer survival on the pathology of CBD. We observed abnormal aggregation of trans-activating response region DNA-binding protein of 43 kDa (TDP-43) and α-synuclein, as well as phosphorylated tau, in neurons of broader regions of the brain, beyond the amygdala and other limbic areas. We found that phosphorylated tau, α-synuclein, and TDP-43 partially co-existed in the same cellular aggregates. The triple pathologic changes might be related to the longer survival of the patient compared with the typical clinical course of patients with CBD. Further investigations are required to support the hypothesis that tauopathy, synucleinopathy, and TDP-43 proteinopathy might share common pathogenic mechanisms in terms of cross-seeding of the pathologic proteins.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Rebeiz JJ, Kolodny EH, Richardson EP Jr (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18:20–33CrossRefPubMed Rebeiz JJ, Kolodny EH, Richardson EP Jr (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18:20–33CrossRefPubMed
2.
Zurück zum Zitat Boeve BF, Lang AE, Litvan I (2003) Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54(Suppl 5):S15–S19CrossRefPubMed Boeve BF, Lang AE, Litvan I (2003) Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54(Suppl 5):S15–S19CrossRefPubMed
3.
Zurück zum Zitat Dickson DW, Bergeron C, Chin SS et al (2002) Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935–946PubMed Dickson DW, Bergeron C, Chin SS et al (2002) Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935–946PubMed
4.
Zurück zum Zitat Feany MB, Dickson DW (1995) Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146:1388–1396PubMedCentralPubMed Feany MB, Dickson DW (1995) Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146:1388–1396PubMedCentralPubMed
5.
Zurück zum Zitat Kouri N, Murray ME, Hassan A et al (2011) Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain 134:3264–3275PubMedCentralCrossRefPubMed Kouri N, Murray ME, Hassan A et al (2011) Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain 134:3264–3275PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Ling H, O’Sullivan SS, Holton JL et al (2010) Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133:2045–2057CrossRefPubMed Ling H, O’Sullivan SS, Holton JL et al (2010) Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133:2045–2057CrossRefPubMed
7.
Zurück zum Zitat Aiba I (2012) Corticobasal syndrome: recent advances and future directions. Brain Nerve 64:462–473PubMed Aiba I (2012) Corticobasal syndrome: recent advances and future directions. Brain Nerve 64:462–473PubMed
8.
Zurück zum Zitat Wenning GK, Litvan I, Jankovic J et al (1998) Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 64:184–189PubMedCentralCrossRefPubMed Wenning GK, Litvan I, Jankovic J et al (1998) Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 64:184–189PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Uryu K, Nakashima-Yasuda H, Forman MS et al (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67:555–564PubMedCentralCrossRefPubMed Uryu K, Nakashima-Yasuda H, Forman MS et al (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67:555–564PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Arai T, Ikeda K, Akiyama H et al (2004) Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol 55:72–79CrossRefPubMed Arai T, Ikeda K, Akiyama H et al (2004) Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol 55:72–79CrossRefPubMed
11.
Zurück zum Zitat Tsuji H, Arai T, Kametani F et al (2012) Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain 135:3380–3391CrossRefPubMed Tsuji H, Arai T, Kametani F et al (2012) Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain 135:3380–3391CrossRefPubMed
12.
13.
Zurück zum Zitat Braak H, Del Tredici K, Rub U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211CrossRefPubMed Braak H, Del Tredici K, Rub U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211CrossRefPubMed
14.
Zurück zum Zitat Galpern WR, Lang AE (2006) Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol 59:449–458CrossRefPubMed Galpern WR, Lang AE (2006) Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol 59:449–458CrossRefPubMed
15.
Zurück zum Zitat Clarimon J, Molina-Porcel L, Gomez-Isla T et al (2009) Early-onset familial Lewy body dementia with extensive tauopathy: a clinical, genetic, and neuropathological study. J Neuropathol Exp Neurol 68:73–82CrossRefPubMed Clarimon J, Molina-Porcel L, Gomez-Isla T et al (2009) Early-onset familial Lewy body dementia with extensive tauopathy: a clinical, genetic, and neuropathological study. J Neuropathol Exp Neurol 68:73–82CrossRefPubMed
16.
Zurück zum Zitat Duda JE, Giasson BI, Mabon ME et al (2002) Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol 104:7–11CrossRefPubMed Duda JE, Giasson BI, Mabon ME et al (2002) Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol 104:7–11CrossRefPubMed
17.
Zurück zum Zitat Galloway PG, Grundke-Iqbal I, Iqbal K, Perry G (1988) Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J Neuropathol Exp Neurol 47:654–663CrossRefPubMed Galloway PG, Grundke-Iqbal I, Iqbal K, Perry G (1988) Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J Neuropathol Exp Neurol 47:654–663CrossRefPubMed
18.
Zurück zum Zitat Giasson BI, Forman MS, Higuchi M et al (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300:636–640CrossRefPubMed Giasson BI, Forman MS, Higuchi M et al (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300:636–640CrossRefPubMed
19.
Zurück zum Zitat Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW (2003) Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol 62:389–397PubMed Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW (2003) Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol 62:389–397PubMed
20.
Zurück zum Zitat Terni B, Rey MJ, Boluda S et al (2007) Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer’s disease. Acta Neuropathol 113:403–416CrossRefPubMed Terni B, Rey MJ, Boluda S et al (2007) Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer’s disease. Acta Neuropathol 113:403–416CrossRefPubMed
21.
Zurück zum Zitat Wills J, Jones J, Haggerty T et al (2010) Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson’s disease brains with and without dementia. Exp Neurol 225:210–218PubMedCentralCrossRefPubMed Wills J, Jones J, Haggerty T et al (2010) Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson’s disease brains with and without dementia. Exp Neurol 225:210–218PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Badiola N, de Oliveira RM, Herrera F et al (2011) Tau enhances alpha-synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS One 6:e26609PubMedCentralCrossRefPubMed Badiola N, de Oliveira RM, Herrera F et al (2011) Tau enhances alpha-synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS One 6:e26609PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Iseki E, Marui W, Kosaka K, Ueda K (1999) Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neurosci Lett 265:9–12CrossRefPubMed Iseki E, Marui W, Kosaka K, Ueda K (1999) Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neurosci Lett 265:9–12CrossRefPubMed
24.
Zurück zum Zitat Hamilton RL (2000) Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10:378–384CrossRefPubMed Hamilton RL (2000) Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10:378–384CrossRefPubMed
25.
Zurück zum Zitat Lippa CF, Fujiwara H, Mann DM et al (1998) Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer’s disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153:1365–1370PubMedCentralCrossRefPubMed Lippa CF, Fujiwara H, Mann DM et al (1998) Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer’s disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153:1365–1370PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Raghavan R, Khin-Nu C, Brown A et al (1993) Detection of Lewy bodies in Trisomy 21 (Down’s syndrome). Can J Neurol Sci 20:48–51PubMed Raghavan R, Khin-Nu C, Brown A et al (1993) Detection of Lewy bodies in Trisomy 21 (Down’s syndrome). Can J Neurol Sci 20:48–51PubMed
27.
Zurück zum Zitat Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ (1999) Antibodies to alpha-synuclein detect Lewy bodies in many down’s syndrome brains with Alzheimer’s disease. Ann Neurol 45:353–357CrossRefPubMed Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ (1999) Antibodies to alpha-synuclein detect Lewy bodies in many down’s syndrome brains with Alzheimer’s disease. Ann Neurol 45:353–357CrossRefPubMed
28.
Zurück zum Zitat Judkins AR, Forman MS, Uryu K et al (2002) Co-occurrence of Parkinson’s disease with progressive supranuclear palsy. Acta Neuropathol 103:526–530CrossRefPubMed Judkins AR, Forman MS, Uryu K et al (2002) Co-occurrence of Parkinson’s disease with progressive supranuclear palsy. Acta Neuropathol 103:526–530CrossRefPubMed
29.
Zurück zum Zitat Forman MS, Schmidt ML, Kasturi S et al (2002) Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. Am J Pathol 160:1725–1731PubMedCentralCrossRefPubMed Forman MS, Schmidt ML, Kasturi S et al (2002) Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. Am J Pathol 160:1725–1731PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Wilhelmsen KC, Forman MS, Rosen HJ et al (2004) 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Arch Neurol 61:398–406CrossRefPubMed Wilhelmsen KC, Forman MS, Rosen HJ et al (2004) 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Arch Neurol 61:398–406CrossRefPubMed
31.
Zurück zum Zitat Yancopoulou D, Xuereb JH, Crowther RA, Hodges JR, Spillantini MG (2005) Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia. J Neuropathol Exp Neurol 64:245–253PubMed Yancopoulou D, Xuereb JH, Crowther RA, Hodges JR, Spillantini MG (2005) Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia. J Neuropathol Exp Neurol 64:245–253PubMed
32.
Zurück zum Zitat Schmidt ML, Martin JA, Lee VM, Trojanowski JQ (1996) Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disorders. Acta Neuropathol 91:475–481CrossRefPubMed Schmidt ML, Martin JA, Lee VM, Trojanowski JQ (1996) Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disorders. Acta Neuropathol 91:475–481CrossRefPubMed
33.
Zurück zum Zitat Mooney T, Tampiyappa A, Robertson T et al (2011) Dual pathology of corticobasal degeneration and Parkinson’s disease in a patient with clinical features of progressive supranuclear palsy. Neurol India 59:887–890CrossRefPubMed Mooney T, Tampiyappa A, Robertson T et al (2011) Dual pathology of corticobasal degeneration and Parkinson’s disease in a patient with clinical features of progressive supranuclear palsy. Neurol India 59:887–890CrossRefPubMed
34.
Zurück zum Zitat Kouri N, Oshima K, Takahashi M et al (2013) Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD. Acta Neuropathol 125:741–752PubMedCentralCrossRefPubMed Kouri N, Oshima K, Takahashi M et al (2013) Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD. Acta Neuropathol 125:741–752PubMedCentralCrossRefPubMed
35.
Zurück zum Zitat Jellinger KA (2011) Interaction between alpha-synuclein and other proteins in neurodegenerative disorders. Sci World J 11:1893–1907CrossRef Jellinger KA (2011) Interaction between alpha-synuclein and other proteins in neurodegenerative disorders. Sci World J 11:1893–1907CrossRef
Metadaten
Titel
Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration
verfasst von
Satoshi Yamashita
Naomi Sakashita
Taro Yamashita
Nozomu Tawara
Masayoshi Tasaki
Kensuke Kawakami
Yoshihiro Komohara
Yukio Fujiwara
Masashi Kamikawa
Takenobu Nakagawa
Teruyuki Hirano
Yasushi Maeda
Masato Hasegawa
Motohiro Takeya
Yukio Ando
Publikationsdatum
01.11.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 11/2014
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7491-8

Weitere Artikel der Ausgabe 11/2014

Journal of Neurology 11/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.